Clinical Trials Directory

Trials / Unknown

UnknownNCT02699528

The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder

Does Methylphenidate, Prescribed for Attention Deficit Disorder, Influence Primary Enuresis in These Children?

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
5 Years – 10 Years
Healthy volunteers
Not accepted

Summary

To assess wether methylphenidate reduces the prevalence of primary nocturnal enuresis in children with attention deficit disorder

Detailed description

Children aged 5 - 10 years newly diagnosed with attention deficit hyperactivity disorder who report primary nocturnal enuresis, Investigators will obtain baseline data (from parents/caregivers) on their sleep habits and enuresis characteristics by questionnaire. After 6 weeks of methylphenidate therapy, prescribed for the attention deficit, a new questionnaire will be filled.

Conditions

Interventions

TypeNameDescription
DRUGmethylphenidateThe drug will be prescribed as indicated for attention deficit disorder

Timeline

Start date
2016-05-01
Primary completion
2017-04-01
Completion
2017-05-01
First posted
2016-03-04
Last updated
2016-09-16

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02699528. Inclusion in this directory is not an endorsement.

The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder (NCT02699528) · Clinical Trials Directory